Cancer Research The Future of Cancer Research: Science and Patient Impact  09 AM Call for Abstracts
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 34, 3058-3061, November 1, 1974]
© 1974 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Pradhan, T. K.
Right arrow Articles by Morris, H. P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Pradhan, T. K.
Right arrow Articles by Morris, H. P.

Kinetic Regulation of Adenylate Kinases from Muscle, Liver, and Hepatoma1

Tapas K. Pradhan, Wayne E. Criss2 and Harold P. Morris

Department of Obstetrics and Gynecology, University of Florida College of Medicine, Gainesville, Florida 32610 [T. K. P., W.E.C.], and Department of Biochemistry, Howard University College of Medicine, Washington, D. C. 20001 [H. P. M.]

Homogeneous preparations of the major adenylate kinases (EC 2.7.4.3) from rat liver, skeletal muscle, and Morris hepatoma 3924A have been compared kinetically. At concentrations of 50 mM, most citric acid-cycle intermediates activated the enzyme from each tissue. The activation constants of citrate for liver, muscle, and hepatoma adenylate kinases were 0.09, 0.26, and 15.8 mM, respectively. It is likely that citrate could effect the in vivo functioning of liver adenylate kinase.

Apparent Michaelis constants were 1.9, 6.2, and 18.0 mM for adenosine 5'-monophosphate and were 7.0, 10.0, and 33.0 mM for adenosine 5'-triphosphate (ATP) with liver, muscle, and hepatoma enzymes, respectively. Citrate decreased the Km (ATP) with liver and muscle adenylate kinases; it decreased the Km (adenosine 5'-monophosphate) with only the muscle adenylate kinase.

Most Hill plot-slope values (for ATP) were near 1.5, indicating partial ligand-ligand cooperativity. Only in the presence of citrate, and with ATP as the variable substrate, was the slope value greater than two for liver adenylate kinase.

Several kinetic studies, in which modulation of the purified enzymes by nucleoside 5'-diphosphates, free fatty acids, mercurial reagents, and detergent, indicate that all three adenylate kinases have distinct and unique kinetic properties.

1 This research was supported by Grants CA-11818, CA-10729, and CA-10906 from the NIH, and Grant F73-UF4 from the Florida Division of the American Cancer Society.

2 Recipient of NIH Research Career Development Award CA-70187.

Received 4/15/74. Accepted 8/ 2/74.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1974 by the American Association for Cancer Research.